| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Nov 29, 2023 | Nov 30, 2023 | SAB Biotherapeutics, Inc. | Chair | Buy | 77.5 | +11,000 | 1.46% | ✗ | $9.8K |
| Oct 14, 2021 | Oct 15, 2021 | SAB Biotherapeutics, Inc. | CEO | Buy | 48.8 | +1,000 | 0.03% | ✗ | $10.1K |
| Jan 14, 2021 | Jan 14, 2021 | SAB Biotherapeutics, Inc. | CEO | Buy | 100.0 | +417,200 | 15.86% | ✗ | $4.2M |